Related Experiment Video

Updated: May 7, 2026

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

Immunotherapy for mold allergy

Christopher A Coop1

  • 1Department of Allergy and Immunology, Wilford Hall Medical Center, 59th Medical Group, 2200 Bergquist Drive Lackland Air Force Base, San Antonio, TX, USA, christopher.coop@us.af.mil.

Clinical Reviews in Allergy & Immunology
|September 24, 2013
PubMed

Insights

Mold immunotherapy shows promise for allergic rhinitis and asthma, but challenges remain in allergen production and study design. More research is needed to identify key mold allergens for effective treatment.

Area of Science:

  • Immunology
  • Allergology
  • Environmental Health

Background:

  • Inhaled mold antigens are significant triggers for allergic rhinitis and asthma.
  • Effective diagnosis and treatment of mold allergy via immunotherapy face challenges.
  • Mold allergens, containing proteases, require specific handling and cannot be mixed with other allergens.

Purpose of the Study:

  • To review existing studies on mold immunotherapy.
  • To identify challenges in mold allergen production for immunotherapy.
  • To assess the current state of research on mold immunotherapy efficacy.

Main Methods:

  • Conducted a literature search in MEDLINE using keywords: mold, allergy, asthma, and immunotherapy.
  • Reviewed peer-reviewed articles and cited references for relevance.
  • Selected articles based on their direct relation to mold immunotherapy.

Main Results:

  • Most immunotherapy studies focus on Alternaria and Cladosporium molds.
  • There is a notable lack of randomized, placebo-controlled trials for mold immunotherapy efficacy.
  • Challenges exist in producing standardized and relevant mold allergen materials.

Conclusions:

  • Mold immunotherapy requires further investigation due to limitations in current research.
  • Additional studies are essential to identify specific molds responsible for allergic diseases.
  • Standardized allergen production and robust clinical trials are needed to advance mold immunotherapy.

More Related Videos

Humanized Mediator Release Assay as a Read-Out for Allergen Potency10:22

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Allergic Reactions02:06

Allergic Reactions

Overview
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...